A 40-year-old man was admitted with a continuous high grade fever accompanying a relatively large solitary liver abscess with septations. A puncture of the abscess revealed gram-negative rods that could be identified histologically as Fusobacterium necrophorum, which was later confirmed by tissue culture. The patient was switched to meropenem and penicillin, and cured of the infection. Fusobacterium necrophorum is a rare bacterium causing potentially fatal liver abscesses in humans. Clinicians should bear Fusobacterium necrophorum in mind when treating patients with an enlarged solitary liver abscess.
Introduction
Pyogenic liver abscesses are the most common type of visceral abscess, with an estimated annual incidence of 2.3 cases per 100,000 population (1) . The median age of onset is just less than 60 years (2, 3) and men are more susceptible than women (1) . Abscesses typically occur when pyogenic bacteria enter the liver via the portal circulation or the biliary tract from an intra-abdominal infection, or by hematogenous spread from a systemic infection (2) . As for clinical symptoms, fever is seen in 89.6% of cases, right upper quadrant pain in 72.2%, and chills in 69.0% (4) . Risk factors for pyogenic liver abscess are diabetes mellitus (5), hepatobilliary or pancreatic disease (6) , and liver transplantation (1), although such abscesses can occur in the absence of any underlying medical conditions. The major sources of pyogenic liver abscess have been reported to be the Klebsiella species, Escherichia coli, and the Enterococcus species (4) . The mortality rate of pyogenic liver abscess has decreased substantially, ranging from 2 to 12 percent, and is related more to comorbidities than the abscess itself (4, 6, 7). Still, it is important to diagnose this disease as early as possible and promptly begin therapy, which includes administration of appropriate antibiotics and percutaneous abscess drainage.
Fusobacterium necrophorum is a nonmotile, gramnegative anaerobe that normally inhabits the pharynx, gastrointestinal tract, female genital organs, and urinary tract (8, 9) . It is clinically relevant for humans because it is a major contributor to Lemierre's syndrome (9, 10) . Fusobacterium necrophorum infection is seen predominantly in males between the ages of 16 to 23 years and most commonly in the months of January to March, the latter for unknown exact reasons (11) . Although Fusobacterium necrophorum is often the etiologic bacterium in liver abscesses in livestock such as cattle (12) , there have been very few cases found in humans.
Herein, we report a patient presenting with a single, relatively large liver abscess infected with Fusobacterium necro- 
Case Report
A 40-year-old man was admitted to our hospital in the month of January suffering from continuous high grade fever that had been nonresponsive to oral clarithromycin 400 mg/day for 5 days followed by moxifloxacin 400 mg/day for 12 days. A nodular lesion in the liver was detected by ultrasonography (US) by his primary physician. Two years prior, the patient commenced treatment for hypertension with olmesartan 20 mg/day orally and diabetes mellitus type 2 with subcutaneous insulin therapy four times daily, both with satisfactory results. The patient was an archeological excavator of 10 years and had never been abroad. He consumed approximately 40 g ethanol daily and was heterosexual. No diseases were noted among his immediate family members.
On examination, the patient was 165 cm tall, weighed 57 kg, and had a body mass index of 20.9 kg/m 2 . His body temperature was 38.3 . He had a remittent fever, but appeared well with no signs of anemia or jaundice in his conjunctiva and presented no abdominal masses or hepatosplenomegaly. He showed no signs of acute sore throat with purulent exudates, cervical or submandibular lymphoadenopathy, or tenderness indicating thrombophlebitis of the internal jugular vein, although he had earlier lost several teeth due to dental caries. Neurological, chest, and abdominal physical examinations revealed no abnormal findings. Laboratory tests on admission (Table 1 ) revealed a shift to the left of white blood cells and inflammatory reaction. The patient had favorable glucose control. A chest X-ray revealed no abnormal shadows.
A relatively large abscess was noted in the posterior segment of the right lobe of the liver by US, which appeared as a homogeneous low echoic cavity with septations surrounding a ring-like low echoic lesion 70×65 mm in diameter (Fig. 1a) . A computed tomography (CT) showed a heterogeneous low density area accompanied with septations within the posterior segments of the liver (Fig. 1b) , whose surrounding area was slightly enhanced in contrast-enhanced CT (Fig. 1c) . The patient was intravenously administered sulbactam/cefoperazone (SBT/CPZ) 6 g/day on admission as an empiric therapy. Antibodies against ameba in both serum and feces were negative, as were blood cultures taken several times for bacteria and fungi. The man received an abscess content fluid puncture and a liver abscess tissue biopsy on hospital day 5 for histological examination. Histopathological findings of the abscess fluid smear uncovered filamentous and slightly curved rods after careful examination (Fig. 2a) . Liver parenchyma surrounding the abscess showed considerable inflammatory cell infiltration that included neutrophils and lymphocytes (Fig. 2b) . Confirmation of Fusobacterium necrophorum from tissue culture incubation was obtained on day 11, and the patient was switched to intravenous meropenem (MEPM) 2 g/day according to antibiotic susceptibility. Ultrasonography 7 days later revealed that the size of abscess had been reduced to 35×35 mm diameter with virtually no lumen. Fever and clinical symptoms disappeared, indicating that the MEPM was effective. The patient was switched to sawacillin orally 750 g/day on day 20. He was discharged on day 23, and sawacillin was discontinued 8 weeks later because the patient showed no signs of relapse, such as fever, abdominal pain, or chills, and based on evidence of abscess disappearance by nonenhanced CT (Fig. 1d) and US (data not shown). His clinical course is shown in Fig. 3 .
Discussion
Unlike its incidence in livestock, liver abscess infected with Fusobacterium necrophorum is extremely rare in humans. All known previous reports are summarized in Ta- ble 2 (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . Liver abscesses in cattle from Fusobacterium necrophorum are considered to be secondary to the primary focus of infection on the ruminal wall through the portal circulation (12, 26, 27) . In humans, the route of liver abscess development is obscure and speculatively different among cases. Here, infiltration into the liver via the portal circulation from diverticula in the colon (25) or hematogenous spread from dental caries (21, 26) may have been the source of infection in the present patient. It could be also considered that risk factors included his controlled diabetes mellitus or moderate alcohol consumption.
An early diagnosis and prompt therapy are needed for liver abscesses infected with Fusobacterium necrophorum since potentially lethal cases with liver abscesses exist (4, 7) It was also reported that an abscess size of greater than 5 cm in diameter as in the present case was a significant prognostic factor for mortality (28) . Here, a definitive diagnosis of bacterial infection was made via tissue cytology and histology and later confirmed by culture, but our suspicion of an etiologic bacterium also contributed to the diagnosis. It is typically considered that microscopic findings alone are sufficient for identification of Fusobacterium necrophorum. Our diagnosis was validated by a positive tissue culture result 6 days after a liver puncture. It has also been reported that most isolates from patients infected with Fusobacterium necrophorum are responsive to metronidazole, but 2% are resistant to penicillin and 15% to erythromycin (11) . Similar to earlier cases (13-20, 22, 24, 25) , the present patient responded to treatment with ampicillin. Pyogenic liver abscesses usually require specific antibiotic therapies with or without drainage, except for cases complicated with an amoebic abscess (29) . Following hospital discharge, antibiotic therapy should be continued for four to six weeks (30) as reported previously (13-20, 22, 24, 25) , although there have been no randomized controlled trials evaluating the optimal treatment duration. Patients showing a good response to initial drainage should be treated with two to four weeks of parenteral therapy, while patients with incomplete drainage should receive four to six weeks of parenteral therapy ( Table 1 ). The remainder of the treatment course may then be completed with oral therapy tailored to culture results (7, 31) .
In conclusion, clinicians should bear in mind that patients who present with a solitary large liver abscess may be infected with Fusobacterium necrophorum and should undergo a histological examination to ensure prompt identification and treatment.
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